-+ 0.00%
-+ 0.00%
-+ 0.00%
NetraMark founder Joseph Geraci joins H.C. Wainwright AI drug discovery conference panel
Share
Listen to the news
NetraMark founder Joseph Geraci joins H.C. Wainwright AI drug discovery conference panel
  • NetraMark founder Joseph Geraci will join H.C. Wainwright’s AI-Based Drug Discovery and Development virtual conference on Oct. 8-9, 2026.
  • Geraci is scheduled for the “Design Got Cheap - Where Is the Defensible Moat?” panel on Oct. 8, 2026, 4:00-5:00 p.m. ET.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. NetraMark Holdings Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202610070838PRIMZONEFULLFEED9841376) on October 07, 2026, and is solely responsible for the information contained therein.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending